Photocure ASA banner

Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 70.7 NOK 1.73% Market Closed
Market Cap: kr1.9B

Photocure ASA
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Photocure ASA
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Photocure ASA
OSE:PHO
Other Items
kr12.2m
CAGR 3-Years
79%
CAGR 5-Years
48%
CAGR 10-Years
N/A
V
Vistin Pharma ASA
OSE:VISTN
Other Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Navamedic ASA
OSE:NAVA
Other Items
-kr186.6m
CAGR 3-Years
-100%
CAGR 5-Years
-59%
CAGR 10-Years
-23%
S
SoftOx Solutions AS
OSE:SOFTX
Other Items
kr10.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
Oncoinvent ASA
OSE:ONCIN
Other Items
kr3.8m
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Photocure ASA
Glance View

Market Cap
1.9B NOK
Industry
Pharmaceuticals

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.

PHO Intrinsic Value
52 NOK
Overvaluation 26%
Intrinsic Value
Price

See Also

What is Photocure ASA's Other Items?
Other Items
12.2m NOK

Based on the financial report for Dec 31, 2025, Photocure ASA's Other Items amounts to 12.2m NOK.

What is Photocure ASA's Other Items growth rate?
Other Items CAGR 5Y
48%

Over the last year, the Other Items growth was -5%. The average annual Other Items growth rates for Photocure ASA have been 79% over the past three years , 48% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett